Navigation Links
Topical treatment shown to inhibit HIV and herpes simplex virus infection

Mount Sinai School of Medicine researchers demonstrated that a gel applied in the vagina provides protection from both the human immunodeficiency virus (HIV) and the herpes simplex Virus. The study, presented at the 12th Conference on Retroviruses and Opportunistic Infections, is the first to show that a gel can retain anti-viral activity within the human vagina.

The study, which was funded by the National Institutes of Health (NIH) investigated the efficacy of PRO 2000, a topical microbicide under development by Indevus Pharmaceuticals, Inc.

"There is an urgent need for the development of safe and effective vaginal microbicides," Marla Keller, M.D., Assistant Professor of Medicine at the Mount Sinai School of Medicine and the researcher who presented the data. "While condoms offer protection against sexually transmitted infections, their effectiveness is limited because they require partner initiation or consent."

According to the United Nations' 2004 report on the global AIDS epidemic, an estimated 40 million people worldwide are living with HIV, and women account for nearly half of those infected. As stated by the World Health Organization, unprotected sex is the predominant mode of HIV transmission, and genital herpes plays a major role in the sexual spread of HIV.

The researchers conducted a prospective, randomized, double blind, placebo-controlled study among 20 HIV-infected women to assess the antiviral activity of PRO 2000 in cervicovaginal lavage (CVL) fluid collected before and one hour after administration of a single intravaginal dose of PRO 2000 gel or a matched placebo gel. CVL specimens were tested for their ability to prevent HIV and HSV infection of susceptible human cells in culture. Levels of inflammatory cytokines were also measured as markers of acute inflammation.

Analyses showed that CVL obtained after the application of PRO 2000 gel reduced both HIV and HSV infectivity by at least 1000-fold compared to C VL obtained at baseline. The effects were highly statistically significant (p<0.001). In contrast, CVL collected from placebo gel recipients showed little or no anti-viral effect. Furthermore, the researchers found similar low levels of inflammatory cytokines in CVL collected from the drug and placebo groups, indicating that PRO 2000 application did not induce an acute inflammatory response.

"An inflammatory responses could potentially increase susceptibility to HIV and limit any protective effect of microbicides." said Betsy Herold, M.D., Professor of Medicine and Chief of Pediatric Infectious Disease at Mount Sinai and the senior investigator on this study. "We are currently conducting a 14-day study to assess whether or not there is an inflammatory response after repeated applications."


'"/>

Source:Mount Sinai Hospital / Mount Sinai School of Medicine


Related biology news :

1. Protein discovery could unlock the secret to better TB treatment
2. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
3. Researchers add new tool to tumor-treatment arsenal
4. Potential treatments for neurofibromatosis
5. Nanoparticles offer new hope for detection and treatment
6. Technique may allow cancer patients to freeze eggs, preserving fertility before starting treatment
7. PET/CT can identify new cancer lesions at early stage, allowing for prompt treatment
8. New understanding of DNA repair may pave way to cancer treatments
9. Multiple-drug resistant gene expression pattern predicts treatment outcome for pediatric leukemia
10. Newer imaging techniques may lead to over-treatment
11. Asymptomatic HIV babies could use earlier treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/20/2018)... SAN FRANCISCO (PRWEB) , ... November 19, 2018 , ... ... plant growing system for the home, today announced a discount of $420 for its ... off the $2690 GroBox if paid in full, with other discount and payment options ...
(Date:11/20/2018)... ... ... Thanks to its long-standing expertise in ID reader development and industrialization, Elyctis ... company now proposes a full range of readers able to satisfy all needs including ... used by professionals either in a fixed location or on the move as well ...
(Date:11/16/2018)... ... November 16, 2018 , ... Bergeson ... Things Chemical™ and it will engage listeners in intelligent, insightful conversation about everything ... surrounding chemicals. B&C’s talented team of lawyers, scientists, and consultants will keep listeners ...
Breaking Biology News(10 mins):
(Date:12/5/2018)... ... December 05, 2018 , ... Leading authority on how to bridge ... with his “The Referral Playbook: How to Increase Sales with Proven Networking Strategies.” ... will go to the Alzheimer’s Foundation of America (AFA). , Itzkowich is hosting ...
(Date:11/28/2018)... ... November 28, 2018 , ... Earlier this month, Lajollacooks4u's Founder and Chef ... experience the height of truffle season. , Her first stop was Umbria, ... in the exclusive Black Truffle Lodge in the small mountain village of Pettino, Chef ...
(Date:11/20/2018)... ... November 20, 2018 , ... Each year Forbes receives thousands of ... which highlights outstanding performance by individuals under 30 years of age. The Forbes 30 ... from Sports and Entertainment to Venture Capital and Science. , In 2017, Visikol ...
(Date:11/13/2018)... Springs, GA (PRWEB) , ... November 12, 2018 ... ... dentist with state-of-the-art practices in Alpharetta and Sandy Springs, now welcomes new ... aligners provide a discreet and comfortable alternative to traditional braces in the Sandy ...
Breaking Biology Technology: